Support for this hypothesis is provided by a recent study [27], which revealed an increased plaque load in APP transgenic mice with global deletion of LXRα or LXRβ, and further reinforced the idea that LXRs and their responsive genes are important determinants in AD pathogenesis [2,14,20]. This evidence concerns the gene APP and Alzheimer disease.